A heterologous prime-boost regime using DNA and recombinant vaccinia virus expressing the Leishmania infantum P36/LACK antigen protects BALB/c mice from cutaneous leishmaniasis

Author： Gonzalo R.M.   del Real G.   Rodriguez J.R.   Rodriguez D.   Heljasvaara R.   Lucas P.   Larraga V.   Esteban M.  

Publisher： Elsevier

ISSN： 0264-410X

Source： Vaccine, Vol.20, Iss.7, 2002-01, pp. : 1226-1231

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Vaccination of Balb/c mice against experimental visceral leishmaniasis with the GP36 glycoprotein antigen of Leishmania donovani

By Paraguai de Souza E.   Bernardo R.R.   Palatnik M.   Palatnik de Sousa C.B.  

Vaccine, Vol. 19, Iss. 23, 2001-04 ,pp. : 3104-3115

Elsevier

Access to resources Recommend Favorite

A prime-boost immunisation regimen using DNA followed by recombinant modified vaccinia virus Ankara induces strong cellular immune responses against the Plasmodium falciparum TRAP antigen in chimpanzees

By Schneider J.   Langermans J.A.M.   Gilbert S.C.   Blanchard T.J.   Twigg S.   Naitza S.   Hannan C.M.   Aidoo M.   Crisanti A.   Robson K.J.   Smith G.L.   Hill A.V.S.   Thomas A.W.  

Vaccine, Vol. 19, Iss. 32, 2001-09 ,pp. : 4595-4602

Elsevier

Access to resources Recommend Favorite

Interferon-gamma-inducing oral vaccination with Leishmania amazonensis antigens protects BALB/c and C57BL/6 mice against cutaneous leishmaniasis

By Pinto E.F.   de Mello Cortezia M.   Rossi-Bergmann B.  

Vaccine, Vol. 21, Iss. 25, 2003-09 ,pp. : 3534-3541

Elsevier

Access to resources Recommend Favorite

Diversified prime and boost protocols using recombinant vaccinia virus and recombinant non-replicating avian pox virus to enhance T-cell immunity and antitumor responses

By Hodge J.W.   McLaughlin J.P.   Kantor J.A.   Schlom J.  

Vaccine, Vol. 15, Iss. 6, 1997-04 ,pp. : 759-768

Elsevier

Access to resources Recommend Favorite

Nasal delivery of chitosan-DNA plasmid expressing epitopes of respiratory syncytial virus (RSV) induces protective CTL responses in BALB/c mice

By Iqbal M.   Lin W.   Jabbal-Gill I.   Davis S.S.   Steward M.W.   Illum L.  

Vaccine, Vol. 21, Iss. 13, 2003-03 ,pp. : 1478-1485

Elsevier

Access to resources Recommend Favorite